Basit öğe kaydını göster

A review of liver function tests during treatment with atypical antipsychotic drugs: A chart review study

dc.contributor.authorYALUG, Irem
dc.contributor.authorAtasoy, Nuray
dc.contributor.authorERDOGAN, Ayten
dc.contributor.authorKonuk, Numan
dc.contributor.authorUSTUNDAG, Yucel
dc.contributor.authorAtik, Levent
dc.contributor.authorOZTURK, Ulkem
dc.date.accessioned2021-03-04T10:14:56Z
dc.date.available2021-03-04T10:14:56Z
dc.date.issued2007
dc.identifier.citationAtasoy N., ERDOGAN A., YALUG I., OZTURK U., Konuk N., Atik L., USTUNDAG Y., "A review of liver function tests during treatment with atypical antipsychotic drugs: A chart review study", PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, cilt.31, sa.6, ss.1255-1260, 2007
dc.identifier.issn0278-5846
dc.identifier.othervv_1032021
dc.identifier.otherav_6c32355c-053a-45fa-b8e3-554988ed214d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/74811
dc.identifier.urihttps://doi.org/10.1016/j.pnpbp.2007.05.005
dc.description.abstractObjective: Atypical antipsychotic drugs commonly cause asymptomatic increase in the liver enzymes and serum bilirubin levels. However they rarely may induce a serious hepatic toxicity. In this article we aimed to evaluate the effect of atypical antipsychotic drugs namely olanzapine, risperidone and quetiapine on the hepatic enzymes and serum bilirubin levels in psychiatric patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectPsikiyatri
dc.subjectTıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleA review of liver function tests during treatment with atypical antipsychotic drugs: A chart review study
dc.typeMakale
dc.relation.journalPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
dc.contributor.department, ,
dc.identifier.volume31
dc.identifier.issue6
dc.identifier.startpage1255
dc.identifier.endpage1260
dc.contributor.firstauthorID64899


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster